U.S. markets close in 3 hours 46 minutes
  • S&P 500

    3,856.91
    +27.57 (+0.72%)
     
  • Dow 30

    31,277.29
    -124.72 (-0.40%)
     
  • Nasdaq

    13,355.84
    +236.41 (+1.80%)
     
  • Russell 2000

    2,210.46
    +10.29 (+0.47%)
     
  • Crude Oil

    62.37
    -1.16 (-1.83%)
     
  • Gold

    1,720.00
    -55.40 (-3.12%)
     
  • Silver

    26.30
    -1.39 (-5.02%)
     
  • EUR/USD

    1.2090
    -0.0096 (-0.79%)
     
  • 10-Yr Bond

    1.4980
    -0.0200 (-1.32%)
     
  • GBP/USD

    1.3947
    -0.0066 (-0.47%)
     
  • USD/JPY

    106.6660
    +0.4360 (+0.41%)
     
  • BTC-USD

    48,270.25
    -2,530.82 (-4.98%)
     
  • CMC Crypto 200

    968.62
    +35.49 (+3.80%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. A webcast of BIOLASE's recorded company presentation will be available on-demand beginning at 6:00 a.m. ET on January 11th, and can be accessed in the investor relations section of BIOLASE's website at www.biolase.com.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)
BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact your H.C. Wainwright representative or BIOLASE's investor relations firm at tkehrli@evcgroup.com.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-present-at-the-hc-wainwrights-bioconnect-2021-investor-conference-301200830.html

SOURCE BIOLASE, Inc.